Reporting Manager
Renaissance Technologies LLC
Symbol
IRWD
Shares outstanding
160,096,797 shares
Disclosed Ownership
8,597,198 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
13 Nov 2024, 14:41:53 UTC
Date of event
15 May 2024

Sponsored

Quoteable Key Fact

"RENAISSANCE TECHNOLOGIES LLC disclosed 5.4% ownership in IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value per share (IRWD) on 15 May 2024."

Quick Takeaways

  • RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G for IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value per share (IRWD).
  • Disclosed ownership: 5.4%.
  • Date of event: 15 May 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Nov 2024, 14:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Renaissance Technologies LLC 5.4% 8,597,198 8,597,198 0 Brian Felczak Chief Financial Officer
Renaissance Technologies Holdings Corporation 5.4% 8,597,198 8,597,198 0 Brian Felczak Vice President